Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 健康政策與管理研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/67305
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor董鈺琪(Yui-Chi Tung)
dc.contributor.authorChi-Yen Huangen
dc.contributor.author黃紀諺zh_TW
dc.date.accessioned2021-06-17T01:27:14Z-
dc.date.available2025-08-18
dc.date.copyright2020-08-27
dc.date.issued2020
dc.date.submitted2020-08-19
dc.identifier.citation1. 衛生福利部. 108年國人死因統計結果. Available at: https://www.mohw.gov.tw/cp-16-54482-1.html. Accessed June, 27, 2020.
2. 衛生福利部. 106年國人死因統計結果. Available at: https://dep.mohw.gov.tw/DOS/cp-3960-42867-113.html. Accessed 0902, 2018.
3. United States Renal Data System. 2018 Annual Data Report. Available at: https://www.usrds.org/2018/view/Default.aspx. Accessed July 3, 2020.
4. United States Renal Data System. 2017 Annual Data Report. Available at: https://www.usrds.org/2017/view/Default.aspx. Accessed May 18, 2018.
5. 衛生福利部. 慢性腎臟病防治. Available at: https://www.nhi.gov.tw/Content_List.aspx?n=D5CC89AE36D48E5E topn=787128DAD5F71B1A. Accessed June 27, 2020.
6. 衛生福利部. 全民健康保險醫療給付費用總額協商參考指標要覽. Available at: https://dep.mohw.gov.tw/NHIC/lp-1665-116.html. Accessed May 13, 2019.
7. Fowler MJ. Microvascular and macrovascular complications of diabetes. 2008;26:77-82. doi: 10.2337/diaclin.26.2.77 %J Clinical Diabetes.
8. 衛生福利部、, 財團法人國家衛生研究院、, 台灣腎臟醫學會. 2016台灣腎病年報. 臺北: 衛生福利部, 2017.
9. 衛生福利部. 初期慢性腎臟病醫療給付改善方案. Available at: https://www.nhi.gov.tw/Content_List.aspx?n=3A330C0196E21624 topn=5FE8C9FEAE863B46. Accessed September 2, 2018.
10. 衛生福利部. 末期腎臟病前期之病人照護與衛教計畫(Pre-ESRD). Available at: https://www.nhi.gov.tw/Content_List.aspx?n=EBDEAEDEC639490C topn=D39E2B72B0BDFA15. Accessed July 3, 2020.
11. 衛生福利部. 糖尿病醫療給付改善方案. Available at: https://www.nhi.gov.tw/Content_List.aspx?n=EBDEAEDEC639490C topn=D39E2B72B0BDFA15. Accessed October 20, 2018.
12. Liao PJ, Lin TY, Wang TC, et al. Long-term and interactive effects of pay-for-performance interventions among diabetic nephropathy patients at the early chronic kidney disease stage. Medicine 2016;95:e3282. doi: 10.1097/md.0000000000003282.
13. Lin CM, Yang MC, Hwang SJ, Sung JM. Progression of stages 3b-5 chronic kidney disease--preliminary results of Taiwan national pre-ESRD disease management program in Southern Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi 2013;112:773-82. doi: 10.1016/j.jfma.2013.10.021.
14. Hsieh HM, Lin MY, Chiu YW, et al. Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017;32:1184-94. doi: 10.1093/ndt/gfw372.
15. Karunaratne K, Stevens P, Irving J, et al. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013;28:2107-16. doi: 10.1093/ndt/gft093.
16. Lin MY, Cheng LJ, Chiu YW, et al. Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study. PloS one 2018;13:e0198387. doi: 10.1371/journal.pone.0198387.
17. Cramm JM, Nieboer AP. Relational coordination promotes quality of chronic care delivery in Dutch disease-management programs. Health care management review 2012;37:301-9. doi: 10.1097/HMR.0b013e3182355ea4.
18. Cramm JM, Nieboer AP. In the Netherlands, rich interaction among professionals conducting disease management led to better chronic care. 2012;31:2493-500. doi: 10.1377/hlthaff.2011.1304.
19. Parchman ML, Pugh JA, Wang CP, Romero RL. Glucose control, self-care behaviors, and the presence of the chronic care model in primary care clinics. Diabetes care 2007;30:2849-54. doi: 10.2337/dc06-2516.
20. Strickland PA, Hudson SV, Piasecki A, et al. Features of the Chronic Care Model (CCM) associated with behavioral counseling and diabetes care in community primary care. Journal of the American Board of Family Medicine : JABFM 2010;23:295-305. doi: 10.3122/jabfm.2010.03.090141.
21. 余珮華, 郭弘典. 慢性腎臟病的評估與治療. 腎臟與透析 2017;29:107-11. doi: 10.6340/kd.2017.29(3).02.
22. National Kidney Foundation Inc. Chronic kidney disease, classification. Available at: https://www.kidney.org/professionals/guidelines/guidelines_commentaries/chronic-kidney-disease-classification. Accessed July 3, 2020.
23. Kidney Disease Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements 2012;3:1-150.
24. 黃智英, 楊郁. 慢性腎臟病衛教簡介. 臺灣腎臟護理學會雜誌 2004;3:81-7.
25. 蘇大成、黃麗卿、湯澡薰、朱基銘、楊燦、蔡住當 孫白游簡曾. 2007 年台灣地區高血壓、高血糖、 高低密度脂蛋白之追蹤調查研究. 臺北: 國民健康署, 2007.
26. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet (London, England) 2008;371:2173-82. doi: 10.1016/s0140-6736(08)60952-6.
27. 衛生福利部、, 財團法人國家衛生研究院、, 台灣腎臟醫學會. 2017台灣腎病年報. 臺北: 衛生福利部, 2017.
28. 吳希文, 史麗珠, 張睿詒, 陳為堅, 楊銘欽. 慢性腎臟病與其相關因子之探討-以社區成人健康檢查資料分析. 台灣公共衛生雜誌 2009;28:374-84. doi: 10.6288/tjph2009-28-05-03.
29. Kuo HW, Tsai SS, Tiao MM, Yang CY. Epidemiological features of CKD in Taiwan. American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49:46-55. doi: 10.1053/j.ajkd.2006.10.007.
30. 李宜苑. 台灣1997~2007年慢性腎臟病盛行率和發生率趨勢及其危險因素之分析 [Dissertation]: 中國醫藥大學, 2010p.
31. Lin YC, Hsu CY, Kao CC, et al. Incidence and prevalence of ESRD in Taiwan renal registry data system (TWRDS): 2005-2012. Acta Nephrologica 2014;28:65-8. doi: 10.6221/an.2014011.
32. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes care 2005;28:164-76.
33. 楊翼寧, 陳銳溢, 王憲奕, 鄭高珍. 糖尿病腎病變的診斷與治療. 內科學誌 2018;29:240-9. doi: 10.6314/jimt.201808_29(4).05.
34. Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical journal of the American Society of Nephrology : CJASN 2017;12:2032-45. doi: 10.2215/cjn.11491116.
35. 財團法人國家衛生研究院. 2015台灣慢性腎臟病臨床診療指引. Available at: https://www.tsn.org.tw/UI/H/H00202.aspx. Accessed July 3, 2020.
36. Chen PM, Wada T, Chiang CK. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience. Clinical and experimental nephrology 2017;21:307-15. doi: 10.1007/s10157-016-1290-8.
37. American Diabetes Association. The 2018 standards of medical care in diabetes. Available at: http://care.diabetesjournals.org/content/41/Supplement_1. Accessed December 4, 2018.
38. 陳河卿, 洪士元. 慢性腎臟病人高血糖治療的新策略. 腎臟與透析 2017;29:159-64. doi: 10.6340/kd.2017.29(4).03.
39. 陳泰瑜, 林麗玫. 慢性腎臟病病人接受透析的時機. 腎臟與透析 2017;29:132-5.
40. Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. The New England journal of medicine 2010;363:609-19. doi: 10.1056/NEJMoa1000552.
41. Susantitaphong P, Altamimi S, Ashkar M, et al. GFR at initiation of dialysis and mortality in CKD: a meta-analysis. American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;59:829-40. doi: 10.1053/j.ajkd.2012.01.015.
42. Maffei S, Savoldi S, Triolo G. When should commence dialysis: focusing on the predialysis condition. Nephro-urology monthly 2013;5:723-7. doi: 10.5812/numonthly.5435.
43. 董鈺琪、鍾國彪、賴美淑. 建立兒童預防保健之品質指標與支付誘因模式先趨研究計畫. 臺北: 行政院衛生署國民健康局99年委託研究計畫, 2010.
44. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes care 2001;24:1815-20.
45. Saunders MR, Lee H, Chin MH. Early winners and losers in dialysis center pay-for-performance. BMC health services research 2017;17:816. doi: 10.1186/s12913-017-2764-4.
46. Hippen BE, Maddux FW. Integrating kidney transplantation into value-based care for people with renal failure. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2018;18:43-52. doi: 10.1111/ajt.14454.
47. Sikka R. Pay for performance in emergency medicine. Annals of emergency medicine 2007;49:756-61. doi: 10.1016/j.annemergmed.2006.06.032.
48. Shakir M, Armstrong K, Wasfy JH. Could Pay-for-Performance Worsen Health Disparities? Journal of general internal medicine 2018;33:567-9. doi: 10.1007/s11606-017-4243-3.
49. Mendelson A, Kondo K, Damberg C, et al. The Effects of Pay-for-Performance Programs on Health, Health Care Use, and Processes of Care: A Systematic Review. Annals of internal medicine 2017;166:341-53. doi: 10.7326/m16-1881.
50. Kondo KK, Wyse J, Mendelson A, et al. Pay-for-performance and veteran care in the vha and the community: a systematic review. Journal of general internal medicine 2018;33:1155-66. doi: 10.1007/s11606-018-4444-4.
51. 陳瑞忻, 陳思嘉, 陳秋月, et al. 慢性腎臟病完整照護計畫介入可延緩腎功能惡化. 臺灣腎臟護理學會雜誌 2010;9:34-44.
52. 衛生福利部. 全民健康保險醫療服務給付項目及支付標準. Available at: https://www.nhi.gov.tw/Content_List.aspx?n=58ED9C8D8417D00B topn=D39E2B72B0BDFA15. Accessed July 3, 2020.
53. Lai CL, Hou YH. The association of clinical guideline adherence and pay-for-performance among patients with diabetes. Journal of the Chinese Medical Association : JCMA 2013;76:102-7. doi: 10.1016/j.jcma.2012.06.024.
54. Chen YR, Yang Y, Wang SC, et al. Multidisciplinary care improves clinical outcome and reduces medical costs for pre-end-stage renal disease in Taiwan. Nephrology (Carlton, Vic) 2014;19:699-707. doi: 10.1111/nep.12316.
55. Anselmi L, Binyaruka P, Borghi J. Understanding causal pathways within health systems policy evaluation through mediation analysis: an application to payment for performance (P4P) in Tanzania. Implementation science : IS 2017;12:10. doi: 10.1186/s13012-016-0540-1.
56. Ngo DK, Sherry TB, Bauhoff S. Health system changes under pay-for-performance: the effects of Rwanda's national programme on facility inputs. Health policy and planning 2017;32:11-20. doi: 10.1093/heapol/czw091.
57. Van Herck P, De Smedt D, Annemans L, Remmen R, Rosenthal MB, Sermeus W. Systematic review: Effects, design choices, and context of pay-for-performance in health care. BMC health services research 2010;10:247. doi: 10.1186/1472-6963-10-247.
58. Tung YC, Chang GM, Chien KL, Tu YK. The relationships among physician and hospital volume, processes, and outcomes of care for acute myocardial infarction. Medical care 2014;52:519-27. doi: 10.1097/mlr.0000000000000132.
59. Lai CL, Hou YH. The association of clinical guideline adherence and pay-for-performance among patients with diabetes. Journal of the Chinese Medical Association : JCMA 2013;76:102-7. doi: 10.1016/j.jcma.2012.06.024.
60. Blumenthal KJ, Chien AT, Singer SJ. Relationship among team dynamics, care coordination and perception of safety culture in primary care. Family practice 2018. doi: 10.1093/fampra/cmy029.
61. Gittell JH. Coordinating mechanisms in care provider groups: relational coordination as a mediator and input uncertainty as a moderator of performance effects. Management Science 2002:1408-26.
62. Wagner EH, Sandhu, N., Coleman, K.,Phillips, K.E., Sugarman, J.R. . Improving Care Coordination in Primary Care. Medical care 2014:S33-S8. doi: 10.1097/MLR.0000000000000197.
63. Parchman ML, Zeber JE, Romero RR, Pugh JA. Risk of coronary artery disease in type 2 diabetes and the delivery of care consistent with the chronic care model in primary care settings: a STARNet study. Medical care 2007;45:1129-34. doi: 10.1097/MLR.0b013e318148431e.
64. Shi Y, Xiong J, Chen Y, et al. The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis. International urology and nephrology 2018;50:301-12. doi: 10.1007/s11255-017-1679-7.
65. Strand H, Parker D. Effects of multidisciplinary models of care for adult pre-dialysis patients with chronic kidney disease: a systematic review. International journal of evidence-based healthcare 2012;10:53-9. doi: 10.1111/j.1744-1609.2012.00253.x.
66. Agency for Healthcare Research and Quality. Care coordination measures atlas update. Available at: https://www.ahrq.gov/ncepcr/care/coordination/atlas.html. Accessed October 16, 2018.
67. Stewart KA, Bradley KWV, Zickafoose JS, Hildrich R, Ireys HT, Brown RS. Care coordination for children with special needs in Medicaid: lessons from Medicare. The American journal of managed care 2018;24:197-202.
68. Noel PH, Parchman ML, Palmer RF, et al. Alignment of patient and primary care practice member perspectives of chronic illness care: a cross-sectional analysis. BMC family practice 2014;15:57. doi: 10.1186/1471-2296-15-57.
69. Bonomi AE, Wagner EH, Glasgow RE, VonKorff M. Assessment of chronic illness care (ACIC): a practical tool to measure quality improvement. Health services research 2002;37:791-820.
70. Steinhaeuser J, Miksch A, Ose D, et al. Questionnaire of chronic illness care in primary care-psychometric properties and test-retest reliability. BMC health services research 2011;11:295. doi: 10.1186/1472-6963-11-295.
71. Cramm JM, Strating MM, Tsiachristas A, Nieboer AP. Development and validation of a short version of the Assessment of Chronic Illness Care (ACIC) in Dutch disease management programs. Health and quality of life outcomes 2011;9:49. doi: 10.1186/1477-7525-9-49.
72. Gittell JH. Relational coordination: guidelines for theory, measurement and analysis. Available at: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.468.6354 rep=rep1 type=pdf. Accessed November 25, 2018.
73. Wells R, Armstrong, T.W., Brossart, D.F. . Using the relational coordination instrument with a diverse patient sample. Medical Care 2018;56:767-74. doi: 10.1097/MLR.0000000000000964.
74. Warfield ME, Chiri G, Leutz WN, Timberlake M. Family well-being in a participant-directed autism waiver program: the role of relational coordination. Journal of intellectual disability research : JIDR 2014;58:1091-104. doi: 10.1111/jir.12102.
75. Gittell JH. Coordinating mechanisms in care provider groups: relational coordination as a mediator and input uncertainty as a moderator of performance effects. Management Science 2002:1408-26.
76. Gittell JH. Relationships between service providers and their impact on customers. Journal of Service Research 2002;4:299-311.
77. Gittell JH. Relational coordination: coordinating work through relationships of shared goals, shared knowledge and mutual respect. Relational Perspectives in Organizational Studies: A Research Companion 2006:74-94.
78. Gittell JH, Fairfield KM, Bierbaum B, et al. Impact of relational coordination on quality of care, postoperative pain and functioning, and length of stay: a nine-hospital study of surgical patients. Medical care 2000;38:807-19.
79. Gittell JH, Weinberg, D., Pfefferle, S., Bishop, C. Impact of relational coordination on job satisfaction and quality outcomes: a study of nursing homes. Human Resource Management Journal 2008;18:154-70. doi: https://doi.org/10.1111/j.1748-8583.2007.00063.x
80. Barrett BJ, Garg AX, Goeree R, et al. A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clinical journal of the American Society of Nephrology : CJASN 2011;6:1241-7. doi: 10.2215/cjn.07160810.
81. Bayliss EA, Bhardwaja B, Ross C, Beck A, Lanese DM. Multidisciplinary team care may slow the rate of decline in renal function. Clinical journal of the American Society of Nephrology : CJASN 2011;6:704-10. doi: 10.2215/cjn.06610810.
82. Thanamayooran S, Rose C, Hirsch DJ. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20:2385-93. doi: 10.1093/ndt/gfi024.
83. Wang SM, Hsiao LC, Ting IW, et al. Multidisciplinary care in patients with chronic kidney disease: A systematic review and meta-analysis. European journal of internal medicine 2015;26:640-5. doi: 10.1016/j.ejim.2015.07.002.
84. Austin PC. The performance of different propensity-score methods for estimating relative risks. Journal of clinical epidemiology 2008;61:537-45. doi: 10.1016/j.jclinepi.2007.07.011.
85. WHO. Process of translation and adaptation of instruments. Available at: https://www.who.int/substance_abuse/research_tools/translation/en/. Accessed 1117, 2019.
86. Schumacker RE, Lomax, R.G. . A beginner's guide to structural equation modeling. 3 ed., New York , U.S.A: Routledge Taylor Francis Group, 2010;211.
87. O'Rourke N, Hatcher, L. A step by step approach to using SAS for factor analysis and structural equation modeling. 2 ed., N.C. U.S.A: SAS Institute Inc., 2014;127,128,193.
88. 林文德, 謝其政, 邱尚志, 吳慧俞, 黃一展. 以傾向分數配對法評估糖尿病論質計酬方案之成效. 台灣公共衛生雜誌 2010;29:54-63. doi: 10.6288/tjph2010-29-01-06.
89. Huang YC, Lee MC, Chou YJ, Huang N. Disease-specific Pay-for-Performance Programs: Do the P4P Effects Differ Between Diabetic Patients With and Without Multiple Chronic Conditions? Medical care 2016;54:977-83. doi: 10.1097/mlr.0000000000000598.
90. Chiu HC, Hsieh HM, Lin YC, et al. Patient assessment of diabetes care in a pay-for-performance program. International journal for quality in health care : journal of the International Society for Quality in Health Care 2016;28:183-90. doi: 10.1093/intqhc/mzv120.
91. Chauvel N, Le Vaillant M, Pelletier-Fleury N. Variation in HbA1c prescription for patients with diabetes in French general practice: an observational study prior to the implementation of a P4P programme. European journal of public health 2013;23:61-6. doi: 10.1093/eurpub/ckr177.
92. Chen JY, Kang N, Juarez DT, Hodges KA, Chung RS, Legorreta AP. Impact of a pay-for-performance program on low performing physicians. Journal for healthcare quality : official publication of the National Association for Healthcare Quality 2010;32:13-21; quiz -2. doi: 10.1111/j.1945-1474.2009.00059.x.
93. Stevens PE, de Lusignan S, Farmer CK, Tomson CR. Engaging primary care in CKD initiatives: the UK experience. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27 Suppl 3:iii5-11. doi: 10.1093/ndt/gfs103.
94. Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton, Vic) 2010;15 Suppl 2:3-9. doi: 10.1111/j.1440-1797.2010.01304.x.
95. Chen N, Hsu CC, Yamagata K, Langham R. Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia. Nephrology (Carlton, Vic) 2010;15 Suppl 2:31-6. doi: 10.1111/j.1440-1797.2010.01309.x.
96. Wei SY, Chang YY, Mau LW, et al. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs. Nephrology (Carlton, Vic) 2010;15:108-15. doi: 10.1111/j.1440-1797.2009.01154.x.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/67305-
dc.description.abstract目標:糖尿病腎病變因其耗費健保資源甚多,後續更因病程進展需要透析治療,實為我國亟應積極照護之慢性疾病,爰我國已針對是類病人提供糖尿病及慢性腎臟病論質計酬方案多種,惟針對多種論質計酬方案之照護結果與照護利用之研究甚少,並缺乏照護協調相關研究。本研究針對多種論質計酬方案對於糖尿病腎病變病人之照護結果及照護利用影響進行探討,並分析照護協調對於該影響是否具有中介效果。
方法:本研究採回溯性世代研究法,利用初級與次級資料,以診所為分析單位,探討糖尿病腎病變病患參加論質計酬方案情形對病患照護結果及照護利用之影響,並分析照護協調於兩者關係間之中介效果。本研究以27家診所之病患為研究對象,在初級資料部分,郵寄「慢性病照護評估工具(Assessment of Chronic Illness Care , ACIC)」結構式問卷,收集醫療相關人員照護協調分數。次級資料則由衛生福利部國民健康署2018年至2019年「基層診所暨社區醫療群推動預防失能之慢性病介入服務試辦獎勵計畫」資料庫,選取本研究個案參加論質計酬方案情形、人口特質、醫療機構特質、照護結果及照護利用等相關變項。使用傾向配對法增加個案之可比較性後,以迴歸分析瞭解參加論質計酬方案情形對病患照護結果及照護利用之影響,並進一步探討照護協調是否對於論質計酬方案與照護結果及照護利用間之關係造成影響。
結果:照護利用(腎絲球過濾率追蹤、糖化血色素追蹤)顯示參加多種論質計酬優於僅參加1種或未參加者,惟照護結果(糖化血色素)卻顯示非P4P組及參加1種P4P組均優於參加2種P4P組。本研究目的二顯示參照組為參加2種P4P組時,非P4P組及僅參加1種P4P組與照護協調分數為負相關,顯示參加較多種論質計酬期照護協調分數較高。研究目的三,慢性病照護協調可顯著降低糖化血色素、血壓、低密度脂蛋白之不良結果。研究目的四顯示對照護結果與照護利用之部分項目有中介效果。
結論:糖尿病腎病變實為影響我國公共衛生之重大疾病,當前已發展為整合照護之論質計酬制度,多種研究結果及本研究結果亦說明結合多項單一疾病論質計酬制度有利於病人之照護利用結果,且多重慢性協調照護亦為推動良好疾病照護成果之要素之一。後續可利用ACIC量表檢視慢性病協調照護要素是否齊備,進而增進醫療服務品質,提供國人更優質之糖尿病腎病變照護。
zh_TW
dc.description.abstractObjective:
Chronic Illness such as diabetes and related complications such as diabetic nephropathy consume large amount health insurance resources, and subsequently require insulin treatment due to the progression of the disease. In fact, these chronic diseases should be actively cared for. Taiwan has demonstrates many studies on the diabetes and chronic kidney disease demonstration qualitative remuneration programs for targeted patients, however, only few studies focus on the care results and care utilization of multiple qualitative remuneration schemes and care coordination. The objective of this study is to analyze whether care coordination has an intermediary effect on the impact between the programs and the care results and care utilization .
Methods:
This study adopts a retrospective generation research method, using primary and secondary data. We have used clinics as the analysis unit to explore the impact of patients with diabetic nephropathy participating in the qualitative remuneration program on patient care results, care utilization, and analyze care coordination of the mediating effect between the two relations. This study took analyzed patients from 27 clinics as the research object. In the primary data section, the 'Assessment of Chronic Illness Care (ACIC)' structured questionnaire was mailed to the clinics, information on care coordination scores of medical personnel was collected. The secondary information is from the National Health Administration of the Ministry of Health and Welfare, using data from 2018 to 2019 in the 'Primary Clinics and Community Medical Groups Promoting Disability Prevention of Chronic Disease Interventional Services Pilot Award Program' database, we have analyzed demographic characteristics, medical institution characteristics, care results and care utilization and other related variables. After using the propensity matching method to increase the comparability of cases, use regression analysis to understand the impact of participation in the quality-based payment plan on the patient's care results and care utilization, and further explore whether care coordination has an effect on the quality-based payment plan, care results, and care utilization rate.
Results:
Care utilization (tracing of glomerular filtration rate, tracking of glycosylated hemoglobin) showed that participating in multiple types of qualitative remuneration was better than participating in only one or not participating, but the care results (glycated hemoglobin) showed that the non-P4P group and participating in one P4P Groups are better than participating in the 2 P4P groups. The second purpose of this study shows that when the reference group is participating in the 2 types of P4P groups, the non-P4P group and the only participation in the 1 type of P4P group are negatively correlated with the care coordination scores, indicating that the care coordination scores of participating in more qualitative remuneration periods are higher. Research objective three, the care coordination for chronic diseases significantly reduce the adverse results of glycated hemoglobin, blood pressure, and low-density lipoprotein. The fourth research objective shows that there is an intermediary effect between the comparison of care results, and some items of care utilization.
Conclusion:
Diabetic nephropathy is actually a major disease that affects public health in Taiwan. It has been developed into an integrated care based on quality and remuneration system. The results of various studies and the results of this study indicate that combining multiple single disease based on quality and remuneration systems is beneficial to patient care. As a result, multiple chronic coordinated care is also one of the factors that  would produce effective and desirable health results. In the future, the ACIC scale can be used as a tool to examin the elements of coordinated care for chronic diseases, thereby improving the quality of medical services and providing better quality diabetic nephropathy care in Taiwan.
en
dc.description.provenanceMade available in DSpace on 2021-06-17T01:27:14Z (GMT). No. of bitstreams: 1
U0001-1608202012414100.pdf: 3322949 bytes, checksum: a77e84205609ec826e90e2d00ec9b19f (MD5)
Previous issue date: 2020
en
dc.description.tableofcontents摘要 III
目錄 VIII
表目錄 IX
圖目錄 XI
第一章 緒論 1
第一節 研究背景 1
第二節 研究目的 4
第二章 文獻探討 5
第一節 慢性腎臟病簡介 5
第二節 慢性腎臟病相關論質計酬制度介紹 11
第三節 論質計酬方案成效評估實證研究 30
第四節 慢性腎臟病與慢性病照護協調 37
第三章 研究方法 46
第一節 研究目的一 46
第二節 研究目的二 53
第三節 研究目的三 57
第四節 研究目的四 59
第四章研究結果 61
第一節描述性分析及雙變項分析 61
第二節 研究目的一 71
第三節 研究目的二 81
第四節 研究目的三 84
第五節 研究目的四 94
第五章 討論 109
第一節 研究方法討論 109
第二節 研究結果討論 112
第三節 研究限制 119
第六章 結論與建議 120
第一節 結論 120
第二節 建議 122
參考文獻 124
附錄慢性病照護評估問卷中文翻譯問卷 132
dc.language.isozh-TW
dc.subject糖尿病腎病變zh_TW
dc.subjectdiabetic nephropathyen
dc.title論質計酬及照護協調對糖尿病腎病變病患照護利用及結果之影響zh_TW
dc.titleImpacts of pay for performance and care coordination on utilization and outcomes of care among diabetic nephropathy patientsen
dc.typeThesis
dc.date.schoolyear108-2
dc.description.degree博士
dc.contributor.oralexamcommittee楊銘欽(Ming-Chin Yang),黃尚志(Shang-Jyh Hwang),洪冠予(Kuan-Yu Hung),李玉春(Yu-Chun Lee)
dc.subject.keyword糖尿病腎病變,zh_TW
dc.subject.keyworddiabetic nephropathy,en
dc.relation.page142
dc.identifier.doi10.6342/NTU202003572
dc.rights.note有償授權
dc.date.accepted2020-08-19
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept健康政策與管理研究所zh_TW
顯示於系所單位:健康政策與管理研究所

文件中的檔案:
檔案 大小格式 
U0001-1608202012414100.pdf
  未授權公開取用
3.25 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved